Motivation: Functional enrichment analysis using primary genomics datasets is an emerging approach to complement established methods for functional enrichment based on pre-defined lists of functionally related genes. Currently used methods depend on creating lists of "significant" and "non-significant" genes based on ad-hoc significance cutoffs. This can lead to loss of statistical power and can introduce biases affecting the interpretation of experimental results. Results: We developed and validated a new statistical framework, Generalized Random Set analysis (GRS), for comparing the genomic signatures in two datasets without the need for gene categorization. In our tests GRS produced correct measures of statistical significance, and it showed dramatic improvement in the statistical power over four existing methods. We also developed a procedure for identifying genes driving the concordance of the genomics profiles and demonstrated a dramatic improvement in functional coherence of genes identified in such analysis.
INTRODUCTION
Elucidating the functional significance of differences in gene expression, or of patterns of different gene expression regulatory events in the context of existing knowledge about gene function has become the most challenging, but also the most rewarding aspect of the genomics data analysis (Rhodes and Chinnaiyan, 2005) . The most commonly used strategy relies on sets of reference lists containing functionally related genes, such as Gene Ontologies (GO) (Ashburner et al., 2000) and KEGG pathways (Kanehisa and Goto, 2000) , to identify functional categories enriched by the differentially regulated genes.
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Statistical methods and computational procedures for identifying functionally related sets of genes that are associated with new experimental data have been studied in detail (Ackermann and Strimmer, 2009; Newton et al., 2007; Sartor et al., 2009; Subramanian et al., 2005; Tian et al., 2005) . Two basic approaches are used to establish statistical significance of such enrichment. The first approach relies on counting the number of genes in a given functional category that are also differentially expressed, and using the Fisher's exact or Chi-squared tests to establish the statistical significance of such overlaps. The inherent limitation of this type of analysis is the requirement to choose statistical significance cutoff levels for differential expression. This can reduce the statistical power of the analysis (Ackermann and Strimmer, 2009; Newton et al., 2007; Sartor et al., 2009; Subramanian et al., 2005) , and different threshold choices may lead to dramatically different enriched categories (Pan et al., 2005) . The second approach uses the complete distribution of differential expressions of all genes to identify enriched gene lists, without categorizing them into differentially and non-differentially expressed. Statistically, these methods use either rank-based Kolmogorov-Smirnov-like tests (Subramanian et al., 2005) , or the traditional location shift tests (Newton et al., 2007; Sartor et al., 2009; Tian et al., 2005) to identify lists of functionally related genes that are "more differentially expressed" than a randomly drawn list of genes of the same length. Systematic performance assessments established that, in general, "location shift" methods using all data outperform Chi-squaredand Kolmogorov-Smirnov-like methods (Ackermann and Strimmer, 2009; Sartor et al., 2009; Tian et al., 2005) .
Comparing a new, experimentally derived gene list to other, predefined lists of functionally related genes, while widely used, has its limitations. Despite the large number of such gene lists, they are often not adequate for precisely characterizing functional consequences of experimentally derived genomics profiles. First, functional relationship does not necessary imply co-expression or coregulation. For example, only a fraction of genes associated with the same GO terms also exhibit coordinated gene expression (Wren, 2009 ). Consequently, a potentially large portion of genes belonging to a functional category or pathway will never be informative about the association between a genomics profile and the pathway. Second, lists associated with a biological concept or a process are often incomplete (Pena-Castillo et al., 2008) .
The alternative is to use the vast array of public domain genomics datasets to perform functional enrichment analysis by primary genomics data. In this approach, newly generated genomics profiles are directly compared to profiles from a large collection of reference genomics datasets. Functional interpretation of new data is then based on phenotypic characteristics of the reference datasets that have concordant genomics profiles. A number of methods use this approach including EXALT (Yi et al., 2007) , EPSA (Tenenbaum et al., 2008) , GEMS (Li et al., 2008) , and GEM-TREND (Feng et al., 2009 ). All these methods categorize genes into "significant" and "non-significant" based on a fixed significance threshold (e.g. FDR<0.1) which can result in loss of statistical power as well as biases as is the case in the traditional analysis of gene sets.
Here, we introduce a new statistical framework, Generalized Random Set (GRS) analysis, to assess the concordance in genomics profiles between two datasets. GRS extends the Random Set (RS) method for functional enrichment analysis by gene lists (Newton et al., 2007) and does not require specification of a significance cutoff for neither the query signature nor the reference datasets. To the best of our knowledge, this is the first method without such a requirement. We first describe our approach in detail and then compare our new method to other existing procedures which employ primary genomics data in this way. We find that GRS outperforms the other methods due in part to the loss of statistical power associated with the categorization of genes that is necessary for the other methods. GRS is implemented in CLEAN R package (available at http://ClusterAnalysis.org/), and the online version is available through Genomics Portals (http://GenomicsPortals.org/) (Shinde et al., 2010) .
METHODS

Generalized Random Set Analysis
Suppose that we calculated measures of differential expression and associated statistical significances for a set of genes G and let sg denote a measure of the level of differential expression for gene g to be used in the analysis. In our case we set
Let pg be an index variable for the membership of each gene in a specific functional category F. pg is set to 1 if gene g is the member of the functional category F and it is set to 0 otherwise:
The Random Set statistics, measuring the overall level of differential expression for genes in F, is defined as the average score for the genes in F.
Under the null hypothesis that there is no enrichment of differentially expressed genes among the genes in category F, the RS statistics is approximately distributed as the normal random variable with the mean μ being equal to the average of sg over all genes and the variance being derived using the simple delta method (Casella and Berger, 2001 This method (Newton et al., 2007) can be applied to our problem by simply using one genomics datasets to create the functional category F by declaring only genes differentially expressed for some cut-off to be members of the category F. Now, suppose we have probabilities of differential expression for each gene g in two datasets (pg 1 and pg 2 ). These probabilities can be estimated based on the p-values for differential expression (Sellke et al., 2001) . To avoid the need for categorizing genes into "significant" and "nonsignificant", we propose to compute a statistic E12 by replacing the index variable pg with pg 1 while the score sg for the other dataset remains the same as defined in equation (1). To make the statistics symmetric with respect to two datasets we also compute the statistics E21 in which the scores and probabilities are reversed and define the overall Generalized Random Set (GRS) statistic as the average of the two:
We derive the approximate distribution for the test statistic ZE, a standardized version of E, under the null hypothesis of no concordance between the two datasets: 
Estimating Probability of Differential Expression
We approximate the probabilities of differential expression based on the p-values of differential expression (Sellke et al., 2001) . The posterior probability of a gene being differentially expressed is the 1-posterior probability of the null hypothesis and can be estimated as: However, equation (8) implies that, a priori, H0 and H1 are equally likely. In other words, the proportion m0 of not differentially expressed genes is assumed to be 0.5. Using the False Discovery Rate approach (Storey and Tibshirani, 2003) we estimate m0 from the data and modify equation (7) 
Identifying genes with concordant patterns
In addition to assessing the existence of the concordant gene expression patterns, it is important to identify genes responsible for this concordance. A straightforward way to rank genes based on the likelihood of concordance is to use the scaled measure Eg of the individual contribution of gene g to the GRS statistics:
where |G| is the total number of genes.
We estimate the null distribution of Eg by first randomly re-assigning gene labels in both, the query and the reference signature and then recomputing Eg for each gene. After repeating this procedure n times, the resulting quantiles are averaged in order to describe the Eg null distribution.
Data preprocessing, differential expression profiles, and gene matching
We use two primary breast cancer gene expression datasets (Miller et al., 2005; Schmidt et al., 2008) and the collection of genome-wide expression experiments systematically assessing small molecule perturbations in vitro ("Connectivity Map") (Lamb et al., 2006) in the analysis. Raw data is preprocessed using the RMA normalization procedures (Irizarry et al., 2003) and the Entrez Gene based custom CDFs (version 10) (Dai et al., 2005) .
Statistical significance of differential expression between two groups of samples (e.g. positive vs. negative Estrogen receptor status (ER+/-)) is assessed using empirical Bayes linear models (Sartor et al., 2006; Smyth, 2004 ). An average expression signature for a given pair of conditions (e.g. ER+ vs. ER-) is computed as the per-gene average difference of log2 expression levels between the conditions. To match genes across datasets, platform-specific identifiers are first mapped to Entrez gene IDs (Maglott et al., 2005) or, if the datasets are from different species, to Entrez HomoloGene IDs. Next, average p-values (geometric mean) and expression measures (arithmetic mean) for each Entrez ID are computed where necessary, and finally genes are matched across datasets by Entrez ID.
Other methods to assess gene list concordance
We compared our GRS analysis to four other methods. All four procedures require sub-setting genes into "differentially expressed" and "not differentially expressed" using a statistical significance cut-off (Table 1) . The alternative methods are as follows.
EPSA (Expression-based Pathway Signature Analysis) (Tenenbaum et al., 2008) . EPSA computes the Spearman correlation coefficient between average differential expression levels in the Query and the Reference datasets for genes with statistically significant differential expression (FDR<0.1) in the Query dataset. If none of the genes had statistically significant differences in expression then the score was set to zero.
EXALT (EXpression signature AnaLysis Tool) (Yi et al., 2007) . This method computes the Total Identity score by considering genes to be differentially expressed if the FDR ("q-value") is less than 0.2. Briefly, genes are assigned to either U (up-regulated), D (down-regulated), or X (uncertain) in both Query and the Reference datasets. The weighted sum of Q-scores (i.e. the -log[q-value]) for discordant genes (U-D, D-U) is then subtracted from the weighted sum of Q-scores for concordant genes (U-U, D-D). Genes assigned to X for either one of the signatures are ignored.
CS (Connectivity Score) (Lamb et al., 2006) . Differentially expressed genes in the Query dataset (FDR ≤ 0.1) are used as the query list and tagged "up" or "down," respectively, based on their average expression signature. The Connectivity Score is then computed using the average reference expression signature as the single "treatment instance" to compute a metric based on the Kolmogorov-Smirnov statistic (Lamb et al., 2006) .
LRpath (Sartor et al., 2009) . This method requires a reference gene list ("functional category") which we defined as the list of differentially expressed genes in the Query dataset (FDR ≤ 0.1). The LRpath p-value was then computed as described in the original publication by testing the differential expression enrichment in the Reference datasets.
Comparing GRS to other methods
To compare GRS to other methods we test their ability to identify concordant expression profiles defined by the ER status of human primary breast tumors between two independent datasets, as well as expression profiles defined by perturbations that are caused by a number of small molecules (Lamb et al., 2006) . Breast cancer datasets (Miller et al., 2005; Schmidt et al., 2008) . For each iteration, we define a Query dataset of size 2N (N = 2 .. 10) by randomly selecting N samples without replacement among ER+ and N samples among ER-samples in the Schmidt dataset (Schmidt et al., 2008) . The Reference datasets are constructed using samples from an independent primary breast cancer dataset (Miller et al., 2005) and consist of a single Target that is constructed in the same way as the Query dataset, and 20 Decoys for which two groups of samples of size N are selected randomly from all remaining samples. Using the five different methods (EPSA, EXALT, CS, LRpath, and GRS) we compute respective 21 scores between the Query and Reference datasets and rank Reference datasets based on these scores. We repeat this procedure 500 times for each N (Figure 1) .
Connectivity map dataset (Lamb et al., 2006) . Here we use the same principle to generate Query and Reference sets except Decoy datasets are based on the true gene expression profiles for perturbants that are different from the Query perturbant: For Query datasets we randomly draw without (Miller et al., 2005) dataset using the Query dataset based on samples from the Schmidt (Schmidt et al., 2008) dataset.
replacement a subset of size N from the pool of samples treated with the same compound (e.g. estrodial, wortmannin, etc.) and then draw N samples from the pool of corresponding control samples. For Target datasets we randomly draw without replacement a subset of size N from remaining pool of samples treated with the same compound and from remaining controls, respectively. For a Decoy dataset we draw N samples from a sample pool treated with a compound other than the query compound and N samples from its corresponding controls. Receiver Operating Characteristics. To compute the True Positive Rate (TPR) we consider only the Query-Target pair a true match, any Query-Decoy pairing is considered false match. For a fixed sample size, we construct Receiver Operating Characteristics (ROC) curves based on the rankings of each Query-Reference pair in 500 trials. For the fixed ranking threshold t (t=1,…,20), True Positive Rates (TPR) are defined as the proportion of trials for which the rank of Query-Target score is less than t and False Positive Rates are the average proportion of Query-Decoy ranks less than t. In case of ties, ranks are assigned randomly among the tied scores. For each sample size we construct ROC curves by varying t from 1 to 21, and summarize them by calculating the area under each such ROC curves (AUC).
RESULTS
We implemented our new approach and the other methods listed in Table 1 and performed a comparison study using expression data from primary human breast cancers (Miller et al., 2005; Schmidt et al., 2008) and the Connectivity Map (Lamb et al., 2006) . We then evaluated each method based on their ability to correctly identify a Target signature concordant with a Query signature among a number of unrelated Decoy signatures. This approach allows us to estimate the specificity and sensitivity of each method while mimicking the functional analysis by primary genomics data where the researcher compares a new dataset (Query) to a diverse collection of existing genomics datasets (References) in order to identify gene signatures that are similar to the Query.
Evaluating GRS measures of statistical significance
To assess how well our null distribution approximates the true null-distribution we plotted the average cumulative distribution of p-values for different sample sizes (Figure 2 ) under the null hypothesis of no concordance (dashed lines) and the alternative hypothesis (solid lines). The distribution under the null hypothesis was simulated by randomly permuting gene labels in the Decoy datasets while leaving the expression data intact. The cumulative distribution of p-values under the null hypothesis fell on the diagonal line indicating perfect control of the Type I error rate. Under the alternative hypothesis (solid lines in Figure 2) p-values were highly enriched by small p-values and enrichments increased with the increased sample size indicating increasing statistical power to detect the concordance.
Evaluating methods using sub-sampling of breast cancer datasets
To compare our GRS approach to existing methods (EPSA, EXALT, Connectivity Score, and LRpath) assessing gene list concordance, we tested their ability to identify concordant expression profiles defined by the ER status of human primary breast tumors among a number of Decoys. The analysis was performed and ROC curves established for a series of sample sizes N Figure 3 .A shows the ROC curve for N=5. GRS (dashed line) clearly outperforms the other methods producing significantly higher TPRs for any given FPR. ROC curves were summarized for each N by calculating the area under each such curve (Figure 3 .B). Our GRS method provided dramatic improvement in precision over four alternative approaches which all rely on designating "differentially expressed" genes. For example, when N=5, allowing 10% false positives will, on average, resulted in 70% TPR for our GRS method and only about 40% TPR for other methods (Figure 3 .A).
Evaluating methods using the Connectivity Map
In this case we tested the ability of different methods to identify datasets generated by using the same "perturbant" as used in the Query dataset. This time, Decoy datasets were not formed based on randomly permuted data, but based on the true gene expression profiles for perturbants different from the Query perturbant. As with the breast cancer data, GRS outperformed alternative methods across all sample sizes, while all methods indicated increased statistical power with increased sample size (Figure 4 ). All methods performed worse in this setting than in the breast cancer data. This is most likely due to the fact that Decoys in the breast cancer data are true decoys since they are based on randomly permuted sample labels, whereas at least some of the decoys generated in the Connectivity Map setting are likely to be similar to the Target as multiple perturbants are affecting the same biological processes and hence produce highly concordant transcriptional signatures.
Identifying genes with concordant patterns
We examined the utility of the gene-level scores (E g ) to identify genes associated with overlapping patterns of expression. As an example, we used two gene expression datasets comparing samples with different proliferation levels in two very distinct biological systems: diets-induced differential proliferation in normal rat mammary epithelium ) and differential proliferation of primary human tumors of different histologic grades (grade 3 vs. grade 1) (Schmidt et al., 2008) . The GRS indicated the existence of a strong concordant gene expression signature in the two datasets (p-value<10 -5 ). The functional analysis of individual datasets using LRpath (Sartor et al., 2009) against Gene Ontologies (GO) (Ashburner et al., 2000) indicated the strong enrichment of cell-cycle related genes. Using LRpath with genelevel GRS scores (E g ) as the independent variable we compared the statistical significance of enrichment of top 10 GO terms with results based on individual datasets ( Figure 5 ). All top 10 GO terms were cell-cycle related and there was a dramatic increase in the statistical significance of these GO terms over the analysis of individual datasets. This indicates that GRS analysis was able to effec- tively identify genes associated with the concordant profiles in the two datasets and accentuate their importance in the functional analysis.
Example: Diets proliferation signature
To demonstrate how the GRS framework can be used to functionally annotate a newly generated genomics dataset, we continue the example shown in Figure 5 involving diets-induced gene expression changes in normal rat mammary epithelium (Medvedovic et al., 2009) . First, we used our web interface (Shinde et al., 2010) to analyze a single reference dataset (query: dataset "BcercDiets", parameter "Diet"; reference: dataset "GSE11121Entrez", parameter: "grade 1" vs. "grade 3"). The resulting gene list contained 7,814 common genes where 123 (396) genes had a gene-specific GRS score greater than the 99 th (95 th ) percentile. These genes were highly enriched for proliferation-related pathways which can be viewed by clicking on the corresponding link on the result page. A heatmap for the top 396 genes showing the relative expression levels for the two data sets can be found in supplemental Figure 1 . Next, we used the procedures implemented in the R to analyze a collection of 2,980 human reference signatures obtained from GEO (Barrett et al., 2009 ) and 3,135 signatures derived from the Connectivity Map (Lamb et al., 2006) . Both reference sets yielded concordant signatures with highly significant GRS scores that complement the proliferation-related functional annotations found by traditional methods. The GEO reference datasets with the most significant scores include a comparison of mesenchymal and proliferative cells in gliomas (accession GDS1815), breast cancer cells with inactivated FOXM1 transcription factor, and (GDS1477) breast cancer cells affected by 17β-estradiol (GDS2324) (Supplemental Table 1 ). The most concordant perturbation signatures are caused by compounds (Etoposide and Methotrexate) that are commonly used in cancer chemotherapies and inhibit DNA replication. The third most significant compound (Monobenzone) also is a cytotoxin which is used for depigmentation therapy but its working mechanism is not yet fully understood (Supplemental Table 2 ). Reference signatures and the R package CLEAN are available for download at our website (http://ClusterAnalysis.org/).
DISCUSSION
We have developed a new method to assess the concordance of gene signatures. We compared our new approach to four existing methods evaluating the ability to identify genomics datasets similar to a query dataset based on their respective gene signatures with the goal of using the phenotypic characteristics of the identified reference sets to elucidate underlying molecular functions of the genomic profile in the new dataset. Each of the methods is designed to functionally annotate a newly derived gene signature and all but one (LRpath) was aimed specifically at primary genomics data. None of the existing methods, however, are designed to use the complete signature without requiring the specification of a significance cutoff. The choice of the optimal cutoff is a difficult problem. A too restrictive cutoff leads to a low number of genes in the signature, particularly in experiments with small sample sizes. Choosing less restrictive cutoffs, on the other hand, often leads to high numbers of genes in the signature which then results in reduced specificity In this example we use Connectivity Map data (Lamb et al., 2006) to compute the EPSA score for two sets of Query and corresponding Reference signatures as described (N=5) and compute the respective ROC curves. Query set 1 is a set of compoundvehicle comparisons with a relatively large number of genes with low pvalues. Set 2 is a more "difficult" set of comparisons where the distribution of p-values for each signature is more uniform. For set 1, the FDR cutoff results in a better ROC curve than for p-value cutoff (upper two curves) while for set 2, the less conservative p-value cutoff produces a better ROC curve than the FDR cutoff (lower two curves). when computing the concordance measures. To illustrate the impact of the cutoff choice on subsequent concordance analyses, we used the Connectivity Map data (Lamb et al., 2006) to first calculate the EPSA score for two sets of Query and corresponding Reference signatures as described (N=5) each time using a) a stringent significance cutoff (FDR < 0.1) and b) a less conservative one (pvalue < 0.01). We then computed the respective ROC curves (Figure 6) . Query set 1 is a set of compound-vehicle comparisons with a relatively large number of genes with low p-values. Set 2 is a more "difficult" set of comparisons where the distribution of pvalues for each signature is more uniform. In the former case, the FDR cutoff was the better choice (i.e. the ROC curve for the FDR cutoff is above the curve for the p-value cutoff) as it resulted in Query signatures that were more informative for the concordance assessment. In the latter case however, FDR proved to be too restrictive and the p-value-based cutoff was the better alternative. That is, ROC curves for set 2 overall are worse than for the less "difficult" set 1 but the curve for the p-value cutoff is above the curve for the FDR cutoff in this case ( Figure 6 ). In an elegant theoretical analysis within their unifying RS framework, Newton (Newton et al., 2007) showed that in certain situations (small number of very significant genes), methods based on categorizing genes can outperform methods that rely on the complete expression profiles in the traditional enrichment analysis by gene lists. While it is possible that this result holds in the context of enrichment by primary data, our procedure indicates that it is probably impossible to a priori define optimal significance cutoffs for assessing the concordance of gene signatures. Consequently, one may always be better off using methods that do not rely on defining such cut-offs. Our method provides additional means to functionally annotate newly generated genomics data exploiting the vast number of datasets publicly available through repositories such as GEO (Barrett et al., 2009) . It is readily available as part of the add-on R package CLEAN (Freudenberg et al., 2009 ) and through our web interface Genomics Portals (Shinde et al., 2010) . The online version (http://GenomicsPortals.org) facilitates the use of datasets uploaded by the user as well as using any one of the >2,000 primary genomics datasets currently deposited in the Genomics Portals as query and reference datasets.
